Bachem Holding

Last updated
Bachem Holding AG
Type Stock company
SIX:  BANB
ISIN CH0012530207
Industry Chemicals, biotechnology, pharmaceuticals
Founded1971
Headquarters Bubendorf, Switzerland
RevenueCHF 261.6 million [1]  (2017)
Number of employees
1057 [1]
Website bachem.com

Bachem Holding AG is a Swiss bio-technology company active in the fields of chemistry, biochemistry and pharmaceuticals. It specializes in the commercial production of peptides and complex organic compounds as active pharmaceutical ingredients, in the production of peptide-based biochemicals and in the development of manufacturing processes for these compounds.[ citation needed ] It was founded in 1971 and is a subsidiary of Ingro Finanz AG. [1] The head office is in Bubendorf in the canton of Basel-Landschaft; there are production sites in Vionnaz in the canton of Valais, in the Californian cities of Vista and Torrance, and in Great Britain in St Helens near Liverpool, with a sales and distribution site in Tokyo.[ citation needed ] At the end of 2017, it had 1057 employees, revenue of CHF 261.6 million, and net income of CHF 41.8 million. [1]

Contents

History

In 2013 the company entered an agreement with GlyTech Inc. to cooperate on the production of glycosylated proteins and peptides. [2] [ promotional source? ]

In 2015 it bought American Peptide, a bio-technology company in Sunnyvale, California. [3]

Related Research Articles

<span class="mw-page-title-main">Novartis</span> Swiss-American multinational pharmaceutical corporation

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022.

<span class="mw-page-title-main">Takeda Pharmaceutical Company</span> Japanese pharmaceutical company

The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company, with partial American and British roots. It is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda.

The Merck Group, branded and commonly known as Merck, is a German multinational science and technology company headquartered in Darmstadt, with about 60,000 employees and a presence in 66 countries. The group includes around 250 companies; the main company is Merck KGaA in Germany. The company is divided into three business lines: Healthcare, Life Sciences and Electronics. Merck was founded in 1668 and is the world's oldest operating chemical and pharmaceutical company, as well as one of the largest pharmaceutical companies globally.

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.

<span class="mw-page-title-main">Roche</span> Swiss multinational healthcare company

<span class="mw-page-title-main">Gedeon Richter (company)</span> Hungarian pharmaceutical company

Gedeon Richter Plc. is a European multinational pharmaceutical and biotechnology company headquartered in Budapest. It is the largest pharmaceutical company in Central and Eastern Europe, with an expanding direct presence in Western Europe, China, Northern America and Latin America. Richter has the largest R&D unit in Central and Eastern Europe and operations in over 50 countries.

Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the Pharmaceutical, Medical device and Biotechnology industries. It also supplies assorted biomedical products, outsourcing services, and animals for research and development in the pharmaceutical industry and offers support in the fields of basic research, drug discovery, safety and efficacy, clinical support, and manufacturing.

Sigma-Aldrich is an American chemical, life science, and biotechnology company owned by the multinational chemical conglomerate Merck Group.

C.H. Boehringer Sohn AG & Co. KG is the parent company of the Boehringer Ingelheim group, which was founded in 1885 by Albert Boehringer (1861–1939) in Ingelheim am Rhein, Germany. As of 2018, Boehringer Ingelheim is one of the world's largest pharmaceutical companies, and the largest private one. Headquartered in Ingelheim, it operates globally with 146 affiliates and more than 47,700 employees. Unlike most large pharmaceutical companies which are listed, the company is private and fully owned by the Boehringer, Liebrecht and von Baumbach families. The company's key areas of interest are: respiratory diseases, metabolism, immunology, oncology and diseases of the central nervous system. Boehringer Ingelheim is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA). The corporate logo of Boehringer Ingelheim depicts a stylized rendition of the central section of the imperial palace of Charlemagne.

<span class="mw-page-title-main">Janssen Pharmaceuticals</span> Belgian pharmaceutical company

<span class="mw-page-title-main">Clariant</span>

Clariant AG is a Swiss multinational speciality chemical company, formed in 1995 as a spin-off from Sandoz. Headquartered in Muttenz, Switzerland, the public company encompasses 74 subsidiaries in 36 countries (2022). Major manufacturing sites are located in Europe, North America, South America, China, and India. In 2022, sales from continuing operations were 5.198 billion CHF.

<span class="mw-page-title-main">Fine chemical</span> Pure chemical substances produced by and for the chemical industry

In chemistry, fine chemicals are complex, single, pure chemical substances, produced in limited quantities in multipurpose plants by multistep batch chemical or biotechnological processes. They are described by exacting specifications, used for further processing within the chemical industry and sold for more than $10/kg. The class of fine chemicals is subdivided either on the basis of the added value, or the type of business transaction, namely standard or exclusive products.

<span class="mw-page-title-main">Ceragenix Pharmaceuticals</span>

Ceragenix Pharmaceuticals, Inc. is a biopharmaceutical company headquartered in Denver, Colorado that develops prescription therapies based on a platform of proprietary surface active technologies—skin Barrier Repair Technology (BRT) and Cerageninis, a new class of broad spectrum anti-infectives. The company discovers, develops and commercializes anti-infective drugs based on its proprietary class of compounds, Ceragenins. Active against a range of gram positive and gram negative bacteria, these agents are being developed as anti-infective medical device coatings and as therapeutics for antibiotic-resistant organisms.

<span class="mw-page-title-main">Jerini</span> German pharmaceutical company

Jerini AG was a pharmaceutical company based in Berlin, Germany, which focused on the discovery and development of novel peptide-based drugs. Using a proprietary technology platform, Peptides-to-Drugs (P2D), Jerini pursued disease indications for which limited, inadequate, or no treatment options exist. As a result, Jerini established a drug pipeline composed of its own programs as well as others in collaboration with partners. Jerini's commercialization strategy was to market new drugs in niche indications independently and in larger indications with partners. Jerini was acquired by Shire plc in 2008.

Straumann Group is a Swiss company based in Basel (Switzerland) manufacturing dental implants and specialized in related technologies. The group researches, develops, manufactures and supplies dental implants, instruments, biomaterials, CADCAM prosthetics, digital equipment, software, and clear aligners for applications in replacement, restorative, orthodontic and preventative dentistry.

<span class="mw-page-title-main">Lonza Group</span> Swiss pharmaceutical and biotech company

Lonza Group is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, North America and South Asia. Lonza was established under that name in the late 19th-century in Switzerland. The company provides product development services to the pharmaceutical and biologic industries, including custom manufacturing of biopharmaceuticals and detection systems and services for the bioscience sector.

<span class="mw-page-title-main">Sartorius AG</span> German pharmaceutical company

Sartorius AG is an international pharmaceutical and laboratory equipment supplier, covering the segments of Bioprocess Solutions and Lab Products & Services.

<span class="mw-page-title-main">Tecan</span> Swiss laboratory instruments manufacturer

Tecan Group Ltd. is a Swiss company providing laboratory instruments and solutions in biopharmaceuticals, forensics, clinical diagnostics and MedTech for pharmaceutical and biotechnology companies, university research departments, diagnostic laboratories and clinics.

<span class="mw-page-title-main">Axpo Holding</span> Swiss energy company

Axpo Holding AG, headquartered in Baden in the canton of Aargau, and its subsidiaries constitute the energy company Axpo. Axpo Holding AG was established in 2001 and is 100-percent publicly owned. The company originates from the former Nordostschweizerischen Kraftwerke AG, NOK.

Adval Tech Holding is a Swiss company based in the canton of Bern, Switzerland. As of December 2020, it is trading with a ticker symbol "ADVN:SW". It functions primarily in the machinery industry for high-volume components manufactured using metal and plastic, primarily for the automotive industry. The company covers the entire value chain, including product, prototype, mold, tool development, and component production and assembly. The firm specializes in the production of tools, punching, forming processes, injection molding, assembly line systems, and serial parts.

References

  1. 1 2 3 4 Company Overview of Bachem Holding AG. Bloomberg. Archived 20 June 2018
  2. Bachem AG and GlyTech, Inc. Announce Co-promotion Agreement. Accessed February 2023.
  3. R.Mullin (2015). "Peptide Manufacturers Stake Out Their Positions" c&en. vol. 93 Issue 17 pp. 16-19. April 27, 2015. Retrieved 19 July 2017.